Venetoclax+Azacytidine+Modified BUCY Conditioning Regimen for Acute Lymphoblastic Leukemia Undergoing Allo-HSCT

Conditions:   Allogeneic Hematopoietic Stem Cell Transplantation;   Acute Lymphoblastic Leukemia Intervention:   Drug: VEN+AZA+Modified BUCY Sponsor:   The First Affiliated Hospital of Soochow University Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials